Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$76.22 - $98.51 $152,440 - $197,020
2,000 New
2,000 $192,000
Q1 2023

May 12, 2023

BUY
$87.74 - $117.27 $2.76 Million - $3.69 Million
31,500 New
31,500 $3.06 Million
Q1 2022

May 13, 2022

SELL
$74.28 - $92.69 $557,100 - $695,175
-7,500 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$71.72 - $91.47 $9.48 Million - $12.1 Million
-132,200 Reduced 94.63%
7,500 $663,000
Q3 2021

Nov 12, 2021

SELL
$74.77 - $85.47 $620,591 - $709,401
-8,300 Reduced 5.61%
139,700 $10.8 Million
Q2 2021

Aug 13, 2021

SELL
$75.51 - $84.79 $1.57 Million - $1.76 Million
-20,800 Reduced 12.32%
148,000 $12.3 Million
Q1 2021

May 14, 2021

BUY
$74.73 - $90.69 $11.9 Million - $14.4 Million
158,800 Added 1588.0%
168,800 $12.7 Million
Q4 2020

Feb 12, 2021

SELL
$72.61 - $90.2 $2.66 Million - $3.3 Million
-36,600 Reduced 78.54%
10,000 $877,000
Q3 2020

Nov 13, 2020

BUY
$71.87 - $131.03 $2.99 Million - $5.45 Million
41,600 Added 832.0%
46,600 $3.55 Million
Q1 2020

May 14, 2020

SELL
$71.37 - $96.85 $2.59 Million - $3.52 Million
-36,300 Reduced 87.89%
5,000 $422,000
Q4 2019

Feb 13, 2020

SELL
$64.27 - $86.37 $1.87 Million - $2.51 Million
-29,100 Reduced 41.34%
41,300 $3.49 Million
Q3 2019

Nov 08, 2019

SELL
$67.4 - $85.11 $1.51 Million - $1.91 Million
-22,400 Reduced 24.14%
70,400 $4.75 Million
Q2 2019

Aug 14, 2019

BUY
$80.35 - $93.9 $1.45 Million - $1.7 Million
18,100 Added 24.23%
92,800 $7.95 Million
Q1 2019

May 15, 2019

SELL
$84.2 - $98.62 $4.18 Million - $4.9 Million
-49,700 Reduced 39.95%
74,700 $6.64 Million
Q4 2018

Feb 13, 2019

SELL
$80.14 - $106.07 $11.9 Million - $15.7 Million
-148,100 Reduced 54.35%
124,400 $10.6 Million
Q3 2018

Nov 13, 2018

BUY
$93.92 - $105.72 $25.6 Million - $28.8 Million
272,500 New
272,500 $26.4 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.